MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Pulmonology (Drugs, Pharmaceuticals, Biotechnology & Biosimilars)
Vicore Pharma Holding
Attachments
Home - Vicore Pharma
Parents
*Architects: Pulmonology (Drugs, Pharmaceuticals, Biotechnology & Biosimilars)
2026: Eight Swedish companies spearheading the country’s biotech scene
FDA _ Fast Track Designation
Industry: Sweden
Children
*Developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF).
*Main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. FDA
Employees 37 (2026)
Founded 2000
Stockholm, Sweden
Jumps
Avalyn Pharma, formerly, Genoa Pharmaceuticals (ALVN)
Celea Therapeutics
Contineum Therapeutics, Inc. (CTNM), formerly, Pipeline Therapeutics
Endeavor BioMedicines
Insmed Incorporated (NASDAQ: INSM)*
Legacy Pharma